GHSI Guardion Health Sciences, Inc.

Guardion Health Sciences is at the forefront of early detection, intervention and monitoring of numerous eye diseases that have epidemic or near-epidemic profiles and for which there is substantial market potential for the early diagnosis and treatment.

$0.17  +0.02 (12.53%)
As of 08/11/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Consumer Staples
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  04/05/2019
Outstanding shares:  61,426,993
Average volume:  1,921,104
Market cap:   $9,416,758
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy